SREBF1 and diabetic kidney disease: Beyond these established mechanisms, morroniside fundamentally reshapes the renal lipid landscape in DKD by downregulating the master lipid regulators sterol regulatory element-binding protein 1/2 (SREBP-1/2) (32).